Not to be confused with Ansamycin or Annimycin. Pharmaceutical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.235.298 |
Chemical and physical data | |
Formula | C26H25IO11 |
Molar mass | 640.379 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Annamycin is an anthracycline antibiotic being investigated for the treatment of cancer.
Further reading
- Priebe W (1995). "Mechanism of action-governed design of anthracycline antibiotics: a "turn-off/turn-on" approach". Current Pharmaceutical Design. 1 (1): 51–68. doi:10.2174/1381612801666220524190711. S2CID 90406009.
- Trevino AV, Woynarowska BA, Herman TS, Priebe W, Woynarowski JM (November 2004). "Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues". Mol Cancer Ther. 3 (11): 1403–10. doi:10.1158/1535-7163.1403.3.11. PMID 15542779.
External links
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |